
Journal of Medicinal Chemistry p. 357 - 366 (1987)
Update date:2022-08-04
Topics:
Lunt, Edward
Newton, Christopher G.
Smith, Christopher
Stevens, Graham P.
Stevens, Malcolm F. G.
et al.
The systematic variation of the potent antitumor agent mitozolomide (1) is extended to cover alteration of substituents at position 6 and 8 and to change the imidazo<5,1-d>-1,2,3,5-tetrazinone (6) skeleton to the isomeric pyrazolo<5,1-d>-1,2,3,5-tetrazino
View MoreShanghai Yuking Water Soluble Material Tech Co., Ltd
Contact:86-21-68286299
Address:4F, 13B, No. 600, South Xinyuan Road 201306, Shanghai, China
Shaanxi King Stone Enterprise Company Limited
Contact:86-29-88353805,13609285751
Address:.209 Keji Road Hi-Tech industrial Develpment Zone .Xian China
website:http://www.ringchemicals.com/
Contact:+1-416-493-6870
Address:Toronto, Canada
Hebei DaPeng Pharm & Chem Co., Ltd.
Contact:86-317-7298678,0576-88861898 88861908
Address:West Songmen Village, East Songmen Town, Wuqiao, Cangzhou, Hebei ,China
Contact:+86-10-62651721
Address:29 Yongxing Road, Daxing District,Beijing China
Doi:10.1021/acs.orglett.7b03509
(2018)Doi:10.1021/ja00328a031
(1984)Doi:10.1021/ol061123c
(2006)Doi:10.1016/0040-4039(91)80043-6
(1991)Doi:10.1039/b605498f
(2006)Doi:10.1007/BF00515636
(1984)